FDA Blow back - Sug review delayed

Anonymous

Guest
Well. now ain't this special. Sug delayed due to FDA overload. Yeah right. The FDA is dishing back a little to Merck for the now open Januvia debacle.

Merck played adolescent games with the FDA on releasing pancreatic Januvia data. Merck played snook legal games to save profits from the only sig drug we have left.

and now the FDA gets a chance to dish a little pay back.

The fifth Schering Shining Star may be asked for more data.

Take that loser pieces of garbage. Thanks Mr Kim...clearly, you have cost the company BILLIONS
 

<